Which trial do we need? Early oral antibiotic therapy for the treatment of gram-negative bloodstream infections
Clinical Microbiology and Infection · 2023
DOI: 10.1016/j.cmi.2023.02.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Pranita D Tamma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: ptamma1@jhmi.edu. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Sepsis, Bacteremia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: ptamma1@jhmi.edu.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zitieren
APA
Tamma, P. D., & Cosgrove, S. E. (2023). Which trial do we need? Early oral antibiotic therapy for the treatment of gram-negative bloodstream infections. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.02.012
Vancouver
Tamma PD, Cosgrove SE. Which trial do we need? Early oral antibiotic therapy for the treatment of gram-negative bloodstream infections. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.02.012
BibTeX
@article{Tamma2023,
author = {Tamma, Pranita D and Cosgrove, Sara E},
title = {Which trial do we need? Early oral antibiotic therapy for the treatment of gram-negative bloodstream infections},
journal = {Clinical Microbiology and Infection},
year = {2023},
doi = {10.1016/j.cmi.2023.02.012}
}
EUVIMED